- Home
- CURR vs KRRO Comparison
CURR vs KRRO Comparison
Compare CURR & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURR
- KRRO
- Stock Information
- Founded
- CURR 2013
- KRRO 2014
- Country
- CURR Singapore
- KRRO United States
- Employees
- CURR N/A
- KRRO N/A
- Industry
- CURR Business Services
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- CURR Consumer Discretionary
- KRRO Health Care
- Exchange
- CURR Nasdaq
- KRRO Nasdaq
- Market Cap
- CURR 151.4M
- KRRO 147.4M
- IPO Year
- CURR N/A
- KRRO 2019
- Fundamental
- Price
- CURR $1.60
- KRRO $31.18
- Analyst Decision
- CURR Strong Buy
- KRRO Strong Buy
- Analyst Count
- CURR 1
- KRRO 7
- Target Price
- CURR $3.50
- KRRO $96.71
- AVG Volume (30 Days)
- CURR 162.0K
- KRRO 235.6K
- Earning Date
- CURR 08-04-2025
- KRRO 11-11-2025
- Dividend Yield
- CURR N/A
- KRRO N/A
- EPS Growth
- CURR N/A
- KRRO N/A
- EPS
- CURR N/A
- KRRO N/A
- Revenue
- CURR $41,092,419.00
- KRRO $6,281,000.00
- Revenue This Year
- CURR N/A
- KRRO $97.27
- Revenue Next Year
- CURR $14.56
- KRRO N/A
- P/E Ratio
- CURR N/A
- KRRO N/A
- Revenue Growth
- CURR N/A
- KRRO N/A
- 52 Week Low
- CURR $0.33
- KRRO $10.29
- 52 Week High
- CURR $7.08
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- CURR 50.53
- KRRO 65.20
- Support Level
- CURR N/A
- KRRO $20.20
- Resistance Level
- CURR $1.71
- KRRO $37.03
- Average True Range (ATR)
- CURR 0.12
- KRRO 3.64
- MACD
- CURR -0.08
- KRRO 0.22
- Stochastic Oscillator
- CURR 88.61
- KRRO 65.30
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.